MedTrace Logo

Intensive Care Decision-making, Survival and Dying Well

NCT06027684 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2025-01-16

No results posted yet for this study

Summary

The goal of this study is to investigate how the experiences of intensive care patients and their end-of-life wishes affect their willingness to accept intensive care treatment at different chances of survival.

The main questions it aims to answer are:

* What can ICU survivors' experiences of ICU treatment tell us about what it would be like to die whilst receiving ICU treatment?
* How do ICU survivors' reflections about what it might be like to die on ICU relate to their own preferences for their end-of-life care?
* What chance of survival would make ICU survivors willing to go through ICU treatment again, in light of the fact that the alternative chance is dying whilst experiencing ICU treatment?
* How does the possibility of reduction in health-related quality of life and functional decline as a result of critical illness impact ICU survivors' willingness to accept ICU treatment again?

Participating in this study will involve filling out a questionnaire and then taking part in an interview. Participants will be recruited through ICU review clinics and ICU steps groups. The study will last for two years and will be conducted at locations convenient to the participants or via zoom.

Conditions

  • Critical Illness

Sponsors & Collaborators

  • The Royal College of Anaesthetists

    collaborator OTHER

  • University of Manchester

    lead OTHER

Principal Investigators

  • Thomas M Donaldson, MB/BChir · University of Manchester

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-02
Primary Completion
2025-09-30
Completion
2025-12-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06027684 on ClinicalTrials.gov